首页 | 本学科首页   官方微博 | 高级检索  
检索        

华蟾素注射液及其活性成份抗肿瘤机制的研究进展
引用本文:朱晓燕.华蟾素注射液及其活性成份抗肿瘤机制的研究进展[J].世界肿瘤杂志,2006,5(4):272-275.
作者姓名:朱晓燕
作者单位:复旦大学附属肿瘤医院中西医结合科,上海200032
摘    要:华蟾素注射液是临床应用较广的抗肿瘤中药制剂,具有抗肿瘤、增强机体免疫力等作用,但对其确切的有效成份仍需进一步研究。本文将近年国内外华蟾素注射液及其活性成份在抑制肿瘤细胞增殖、诱导肿瘤细胞分化、促进肿瘤细胞凋亡、提高机体免疫力等方面的实验研究进行综述,供临床应用参考。

关 键 词:华蟾素  活性成份  抗肿瘤机制  研究进展
文章编号:1683-0342(2006)04-0272-04
收稿时间:2006-01-28
修稿时间:2006-05-16

Research progress on the antitumor mechanism of Cinobutacini injection and its active ingredient
ZHU Xiao-yan, LIU Lu-ming.Research progress on the antitumor mechanism of Cinobutacini injection and its active ingredient[J].Tumour Journal of the World,2006,5(4):272-275.
Authors:ZHU Xiao-yan  LIU Lu-ming
Institution:Department of Integrative Oncology, Cancer Hospital, Fudan University, Shanghai 200032, China
Abstract:Cinobutacini injection is widely used on the clinic, which has antitumor effects and immunity improvement, but the active ingredient needs to be studied further. The paper summarized the recent research progress on the antitumor mechanism of Cinobutacini injection and its active ingredient, such as inhibition of proliferation, differentiation, apoptosis, and improvement of immunity.
Keywords:Cinobutacini injection  active ingredient  antitumor mechanism  research progress
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号